Maiorana 2007.
Study characteristics | |||
Patient sampling |
Primary objective: to evaluate if serum CA‐125 levels correlate with rAFS and whether serum CA‐125 measurement should be performed in the routine work‐up of dysmenorrhoea and dyspareunia Participants: women who underwent laparoscopy for infertility, ovarian cyst or suspected endometriosis (endometriosis group) and women operated for ovarian cysts and confirmed not to have endometriosis (controls) Selection criteria: exclusion criteria: patients with malignant tumours or inflammatory disease Study design: cross‐sectional two‐gate, prospective collection of samples |
||
Patient characteristics and setting |
Clinical presentation: In endometriosis group: dysmenorrhoea ‐ 52%, dyspareunia ‐ 26%, asymptomatic ‐ 22%; controls ‐ ovarian cysts Age: mean age 33.6 ± 7.3 years, range 21‐54 years Number of participants enrolled: 86 women Number of participants available for analysis: 86 women (in follicular phase of menstrual cycle) Setting: obstetrics and gynaecology units, Civic Hospital Place of study: Paleromo, Italy Period of study: not stated Language: English |
||
Index tests |
Index test: CA‐125 Details of the index test procedure as stated: serum CA‐125 levels were measured by enzyme immunoassay and were expressed in arbitrary units based on a primary reference standard; no other information provided Threshold for positive result: > 35 U/ml, pre‐specified Examiners: no information provided; unclear if were blinded to the result of reference standard Interobserver variability: not provided |
||
Target condition and reference standard(s) |
Target condition: endometriosis Prevalence of target condition in the sample: n = 69/86 (79%): stage I‐II 14, stage III‐IV 55; controls n = 17 Reference standard: laparoscopy N = 86 (100%) Description of positive case definition by reference standard test as reported: surgical diagnosis, rASRM classification Examiners: no information provided |
||
Flow and timing |
Time interval between index test and reference standard: not specified, but statement 'preoperative blood sample' implies short time before surgery Withdrawals: none |
||
Comparative | |||
Key conclusions by the authors | CA‐125 levels are related to endometriosis and rAFS score in the evaluated patient series; no correlation was found between CA‐125 and pelvic pain with endometriosis | ||
Conflict of interest | Not reported | ||
Notes | The presented diagnostic estimates according to severity of endometriosis are not included in this review | ||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | No | ||
Did the study avoid inappropriate exclusions? | Yes | ||
Was a 'two‐gate' design avoided? | No | ||
High | High | ||
DOMAIN 2: Index Test All tests | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Unclear | ||
If a threshold was used, was it pre‐specified? | Yes | ||
Was a cycle phase considered in interpretation of the result of index test? | Yes | ||
Unclear | Low | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Unclear | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Yes | ||
Unclear | Low | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Yes | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Yes | ||
Low |